Evaluation of Clinical Pharmacist-Led Ambulatory Blood Pressure Monitoring Service and its Impact on Hypertension Outcomes in a Primary Care Setting
Files
Publication Date
4-29-2026
Keywords
oregon, pmg, pmg pharmacy
Disciplines
Medical Education
Abstract
Abstract: Based on current hypertension treatment guidelines, ambulatory blood pressure monitoring (ABPM) is one of the preferred methods to obtain out-of office BP measurements for the diagnosis and management of hypertension. It is considered the gold-standard for identifying white-coat hypertension, masked hypertension, and resistant hypertension. ABPM is commonly underutilized due to cost and other factors, which has the potential to contribute to hypertension treatment disparities. In 2017, a pharmacist-led ABPM service was introduced at Providence Medical Group (PMG) at St. Vincent. During the first year of use at PMG at St. Vincent, 53 patients completed ABPM, and the results were positive: 87% of pharmacist recommendations were accepted and/or implemented and 84% of patients were at their HTN goal at follow-up. Since then, pharmacist-led ABPM services have been implemented at many other PMG primary care clinics in Oregon; however, the impact of this expansion has not been studied. The purpose of this study is to evaluate the impact of pharmacist-led ABPM services on hypertension outcomes in the primary care setting. This is a multi-center retrospective chart review that used a Slicer Dicer report to identify the total number of ABPM exams completed at PMG Oregon Primary Care clinics from April 1, 2024, to April 1, 2025. One hundred and fifty patients were randomly selected for data collection. Patients whose ABPM results were not evaluated by a clinical pharmacist or did not complete ABPM were excluded. Data collection will include baseline characteristics and demographics, reason for referral, baseline blood pressure, ABPM findings, relevant medication changes, pharmacist clinical intervention, and blood pressure findings at least six months after ABPM. Collected data will be used to assess whether pharmacist recommendations were implemented and the impact that recommendation had on blood pressure control. Results and conclusions will be shared upon completion of this clinical inquiry. (IRB exempt) Learning Objectives: Describe the impact of pharmacist-led ambulatory blood pressure monitoring services on hypertension outcomes Presentation Category: Ambulatory Care/Disease State Management
Specialty/Research Institute
Graduate Medical Education
Specialty/Research Institute
Pharmacy
